XRAY

Dentsply Sirona Inc

XRAY, USA

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

https://www.dentsplysirona.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
XRAY
stock
XRAY

Market Pulse: Will XRAY stock benefit from commodity prices - July 2025 Short Interest & Community Trade Idea Sharing moha.gov.vn

Read more →
XRAY
stock
XRAY

(XRAY) as a Liquidity Pulse for Institutional Tactics news.stocktradersdaily.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$12.9643

Analyst Picks

Strong Buy

2

Buy

2

Hold

13

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Low

1.56

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-28.89 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-7.55 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

4.42 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.82

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 116.94% of the total shares of Dentsply Sirona Inc

1.

Vanguard Group Inc

(10.5958%)

since

2025/06/30

2.

BlackRock Inc

(10.0582%)

since

2025/06/30

3.

Arnhold & S. Bleichroeder Advisers, LLC

(7.1153%)

since

2025/06/30

4.

AQR Capital Management LLC

(6.6756%)

since

2025/06/30

5.

Fuller & Thaler Asset Management Inc

(6.2128%)

since

2025/06/30

6.

T. Rowe Price Associates, Inc.

(5.4876%)

since

2025/06/30

7.

First Eagle Global A

(5.2315%)

since

2025/07/31

8.

Lazard Asset Management LLC

(5.0669%)

since

2025/06/30

9.

FullerThaler Behavioral Small-Cap Value

(4.9166%)

since

2025/06/30

10.

Undiscovered Managers Behavioral Val L

(4.7156%)

since

2025/07/31

11.

Cooke & Bieler LP

(4.5891%)

since

2025/06/30

12.

State Street Corp

(3.5591%)

since

2025/06/30

13.

iShares Core S&P Mid-Cap ETF

(3.2519%)

since

2025/08/31

14.

Vanguard Total Stock Mkt Idx Inv

(3.1759%)

since

2025/07/31

15.

T. Rowe Price US Mid-Cap Value Equity

(3.1407%)

since

2025/06/30

16.

Dimensional Fund Advisors, Inc.

(2.9348%)

since

2025/06/30

17.

Nuance Mid Cap Value Institutional

(2.6306%)

since

2025/01/31

18.

Vanguard Small Cap Index

(2.4283%)

since

2025/07/31

19.

Geode Capital Management, LLC

(1.8043%)

since

2025/06/30

20.

T. Rowe Price U.S. Mid-Cap Val Eq Tr-D

(1.708%)

since

2025/06/30

21.

Morgan Stanley - Brokerage Accounts

(1.6499%)

since

2025/06/30

22.

Vanguard Small Cap Value Index Inv

(1.5562%)

since

2025/07/31

23.

Edmond de Rothschild Holding S.A.

(1.5476%)

since

2025/06/30

24.

Millennium Management LLC

(1.4996%)

since

2025/06/30

25.

Invenomic Capital Management, LP

(1.4666%)

since

2025/06/30

26.

Lazard Global Eq Franchise A Acc USD

(1.3225%)

since

2025/08/31

27.

NORGES BANK

(1.2532%)

since

2025/06/30

28.

Vanguard Selected Value Inv

(1.1841%)

since

2025/06/30

29.

Charles Schwab Investment Management Inc

(1.1326%)

since

2025/06/30

30.

Northern Trust Corp

(1.0765%)

since

2025/06/30

31.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0732%)

since

2025/07/31

32.

Bank of New York Mellon Corp

(1.0594%)

since

2025/06/30

33.

Qube Research & Technologies

(1.025%)

since

2025/06/30

34.

ROPS Actions US 1

(0.8397%)

since

2025/07/31

35.

Invenomic Institutional

(0.7934%)

since

2025/04/30

36.

SPDR® S&P MIDCAP 400 ETF Trust

(0.7653%)

since

2025/07/31

37.

AQR Long-Short Equity I

(0.6631%)

since

2025/06/30

38.

First Eagle Amundi International AU-C

(0.649%)

since

2025/07/31

39.

iShares S&P Mid-Cap 400 Value ETF

(0.545%)

since

2025/08/31

40.

Fidelity Extended Market Index

(0.5357%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.4779

Latest Release

Date

2025-09-30

EPS Actual

0.37

EPS Estimate

0.4488

EPS Difference

-0.0788

Surprise Percent

-17.5579%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(3.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.